WHY IT MATTERS: If you are currently using commercially available hemp-derived intoxicants such as delta-8 or delta-10 products, you may be consuming synthetic cannabinoids or illegal THC levels without any labeling disclosure to warn you. CLINICAL OVERVIEW: Unregulated intoxicating hemp products pose a serious public health concern because many contain delta-9 THC concentrations above the federal 0.3% legal threshold, effectively making them unregistered cannabis products sold without the consumer protections of a licensed dispensary system. More alarming is the presence of synthetic cannabinoids in a significant proportion of these products, compounds with unpredictable pharmacology, narrow safety margins, and no established therapeutic dosing data.
The association between cannabis use and brain reward anticipation: a 12-month … – Nature
WHY IT MATTERS: If you or someone you care for uses cannabis regularly and has concerns about mood, motivation, or mental health, this emerging research on reward brain circuitry underscores why timing, potency, and age of first use are factors worth discussing openly with a knowledgeable clinician. CLINICAL OVERVIEW: The endocannabinoid system plays a central role in regulating reward circuitry, and THC directly modulates dopaminergic signaling in ways that can alter how the brain anticipates and responds to rewarding stimuli. This is particularly relevant during adolescence and young adulthood, when reward-related neural networks are still developing and may be more vulnerable to disruption from exogenous cannabinoids.
Daily Digest: Last 24 Hours: Adolescent Brain Risk, Harm Reduction Gaps, and the Policy Patchwork — February 26, 2026
A synthesis of 20 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.
Lynn Silver, MD, MPH, FAAP, warns of psychiatric risks with adolescent cannabis use
WHY IT MATTERS: Parents and young people should understand that cannabis use during adolescence is not a low-stakes decision, because the developing brain processes cannabinoids very differently than an adult brain does, with potential consequences for long-term mental health. CLINICAL OVERVIEW: Adolescent cannabis use carries meaningful psychiatric risks because the developing brain, particularly the endocannabinoid system, is uniquely vulnerable to disruption from exogenous cannabinoids during the years of active neurodevelopment that extend into the mid-twenties. Exposure during this window has been associated with increased rates of anxiety, depression, and psychosis, with higher-potency THC products amplifying these concerns considerably.
Lynn Silver, MD, MPH, FAAP, warns of psychiatric risks with adolescent cannabis use
WHY IT MATTERS: Teenagers and parents should know that cannabis use during adolescence is not simply a lifestyle choice but a neurological exposure that may meaningfully increase the risk of serious, lifelong psychiatric conditions. CLINICAL OVERVIEW: Adolescent cannabis use carries meaningful psychiatric risk, particularly for conditions like psychosis and bipolar disorder, during a developmental window when the brain is especially vulnerable to THC’s effects on dopaminergic and endocannabinoid signaling. The association between early cannabis exposure and a doubling of risk for these disorders reflects both biological susceptibility and the potency of today’s high-THC products compared to earlier decades.
Melt-Down Cannabis Gummies: Remix Flavor, Sourness, and Dose With a Simple Calculator
A faster way to make cannabis gummies without starting from scratch. Melt down store-bought gummies gently, mix in your infusion, and use the on-page calculator to dial in mg per piece. Then remix the fun part: flavor boosts, sour coating, and texture tweaks that store cleanly and dose predictably.
Wisconsin Democrats File Bill to Legalize Adult-Use, Medical Cannabis; Regulate Intoxicating Hemp
WHY IT MATTERS: If this bill passes, Wisconsin patients could gain legal access to medical cannabis while a dedicated research fund begins generating state-level data that could eventually inform safer, more evidence-based prescribing guidance. CLINICAL OVERVIEW: Wisconsin Democrats have introduced legislation that would establish a legal framework for both adult-use and medical cannabis in the state, while also creating regulatory guardrails around intoxicating hemp-derived products. A key feature of the proposal is a dedicated excise tax on flower sales that would direct revenue into a Cannabis Research Fund, signaling an intent to pair legalization with scientific inquiry.
Health department providing safe-storage marijuana bags in vending machines – WBAL-TV
WHY IT MATTERS: If cannabis is stored at home without child-resistant containers, even occasional or recreational adult use significantly increases the risk of accidental ingestion and emergency room visits for children in that household. CLINICAL OVERVIEW: Cannabis legalization for adults in Maryland has been accompanied by an unintended consequence seen across many states: increased accidental exposures in children and a rise in cannabis-related emergency visits among both pediatric and adult populations. Proper storage is one of the most evidence-supported harm reduction strategies available, as the majority of pediatric ingestions occur when cannabis products are left accessible in the home.
Major study finds strong link between cannabis, anxiety and depression – Medical Xpress
WHY IT MATTERS: If you are using cannabis to manage anxiety or low mood, this research reinforces the importance of discussing your use openly with a knowledgeable clinician who can help evaluate whether cannabis is helping, harming, or simply co-existing with your mental health symptoms. CLINICAL OVERVIEW: Large-scale observational data from Canadian populations consistently shows that cannabis use and mental health conditions such as anxiety and depression tend to cluster together, but establishing the direction of that relationship remains scientifically complex. Bidirectional associations are well-documented, meaning that some individuals use cannabis to manage pre-existing symptoms while others may experience worsening mood or anxiety as a consequence of use, particularly with high-THC products and frequent consumption patterns.
Modern Cannabis Is Hitting Gen Z Mental Health Hard – Neuroscience News
WHY IT MATTERS: Young people who use high-potency cannabis products frequently should understand that their risk for developing or worsening anxiety and depression is meaningfully elevated compared to non-users or infrequent users, and that risk increases the earlier in adolescence use begins. CLINICAL OVERVIEW: The relationship between high-potency cannabis and mental health conditions such as anxiety and depression is not incidental, and the shift toward products with dramatically elevated THC concentrations over recent decades has outpaced what most young developing brains can tolerate without consequence. Gen Z has grown up with near-unrestricted access to concentrates, vape cartridges, and edibles that bear little resemblance to the cannabis of prior generations, making direct comparisons across age cohorts scientifically problematic but still clinically instructive.